Listed by the USPTO as SOROUSH, ALI
Tech Center 1600 • Art Units: 1600 1611 1614 1616 1617 1629
This examiner grants 47% of resolved cases
SOROUSH, ALI works in tech center 1600 and art unit 1600. The profile includes 792 resolved cases, a 46.7% allowance rate, and a median of 1327 days to allowance. The allowance rate indicates a demanding prosecution record, and the median timing suggests that applications may remain active through an extended examination process.
The interview lift is 30.9%, which makes interviews a potentially important tool for addressing examination issues. Biotronik SE & Co. KG, Retune Pharma Inc., and Ono Pharmaceutical Co., Ltd. are the leading companies. The principal firms are Lewis Kohn & Walker LLP, SUGHRUE-265550, and WILSON SONSINI GOODRICH & ROSATI.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18273708 | Materials and Methods for Treating Viral and Other Medical Conditions | Non-Final OA | Biotronik AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy46.7% of resolved applications examined by Ali Soroush were allowed (792 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +30.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Ali Soroush took 1,327 days on average from filing to allowance.
Ali Soroush examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
